Last reviewed · How we verify
CKD-348 F1, CKD-348 F2, CKD-828, D326, D337
CKD-348 F1, CKD-348 F2, CKD-828, D326, D337 is a Small molecule drug developed by Chong Kun Dang Pharmaceutical. It is currently in Phase 1 development.
At a glance
| Generic name | CKD-348 F1, CKD-348 F2, CKD-828, D326, D337 |
|---|---|
| Sponsor | Chong Kun Dang Pharmaceutical |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-348 in Healthy Volunteers (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- CKD-348 F1, CKD-348 F2, CKD-828, D326, D337 CI brief — competitive landscape report
- CKD-348 F1, CKD-348 F2, CKD-828, D326, D337 updates RSS · CI watch RSS
- Chong Kun Dang Pharmaceutical portfolio CI
Frequently asked questions about CKD-348 F1, CKD-348 F2, CKD-828, D326, D337
What is CKD-348 F1, CKD-348 F2, CKD-828, D326, D337?
CKD-348 F1, CKD-348 F2, CKD-828, D326, D337 is a Small molecule drug developed by Chong Kun Dang Pharmaceutical.
Who makes CKD-348 F1, CKD-348 F2, CKD-828, D326, D337?
CKD-348 F1, CKD-348 F2, CKD-828, D326, D337 is developed by Chong Kun Dang Pharmaceutical (see full Chong Kun Dang Pharmaceutical pipeline at /company/chong-kun-dang-pharmaceutical).
What development phase is CKD-348 F1, CKD-348 F2, CKD-828, D326, D337 in?
CKD-348 F1, CKD-348 F2, CKD-828, D326, D337 is in Phase 1.